New thyroid drug shows promise in phase 2 trial

NCT ID NCT05712421

Completed Disease control Sponsor: Neuvosyn Laboratories, LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new hormone replacement therapy called North Star against the standard drug levothyroxine in 303 adults with hypothyroidism. The goal was to find the right dose of North Star to keep thyroid hormone levels normal. Participants were already stable on levothyroxine and were switched to North Star to see if it worked as well.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypothyroidism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOTHYROIDISM

Contacts and locations

Show contact details

Locations

Neuvosyn Investigational Site

Birmingham, Alabama, 35209, United States
Neuvosyn Investigational Site

Canoga Park, California, 91304, United States
Neuvosyn Investigational Site

Greenbrae, California, 94904, United States
Neuvosyn Investigational Site

Toluca Lake, California, 91602, United States
Neuvosyn Investigational Site

Farmington, Connecticut, 06030, United States
Neuvosyn Investigational Site

Boca Raton, Florida, 33434, United States
Neuvosyn Investigational Site

Miami, Florida, 33144, United States
Neuvosyn Investigational Site

Miami, Florida, 33145, United States
Neuvosyn Investigational Site

Miami, Florida, 33155, United States
Neuvosyn Investigational Site

Miami, Florida, 33174, United States
Neuvosyn Investigational Site

Miami, Florida, 33179, United States
Neuvosyn Investigational Site

Sunrise, Florida, 33351, United States
Neuvosyn Investigational Site

Acworth, Georgia, 30101, United States
Neuvosyn Investigational Site

Atlanta, Georgia, 30318, United States
Neuvosyn Investigational Site

Columbus, Georgia, 31904, United States
Neuvosyn Investigational Site

Sugar Hill, Georgia, 30024, United States
Neuvosyn Investigational Site

Saginaw, Michigan, 48602, United States
Neuvosyn Investigational Site

Gladstone, Missouri, 64118, United States
Neuvosyn Investigational Site

Williamsville, New York, 14221, United States
Neuvosyn Investigational Site

Denver, North Carolina, 28037, United States
Neuvosyn Investigational Site

Winston-Salem, North Carolina, 27103, United States
Neuvosyn Investigational Site

Beavercreek, Ohio, 45440, United States
Neuvosyn Investigational Site

Columbus, Ohio, 31904, United States
Neuvosyn Investigational Site

Georgetown, Texas, 78628, United States
Neuvosyn Investigational Site

Houston, Texas, 77040, United States
Neuvosyn Investigational Site

Katy, Texas, 77450, United States
Neuvosyn Investigational Site

Katy, Texas, 77494, United States
Neuvosyn Investigational Site

Lewisville, Texas, 75067, United States
Neuvosyn Investigational Site

Paris, Texas, 75462, United States
Neuvosyn Investigational Site

Pearland, Texas, 77584, United States
Neuvosyn Investigational Site

Stafford, Texas, 77477, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.